Health ❯ Healthcare ❯ Oncology

Prostate Cancer

Diagnosis Radiotherapy Treatment Metastatic Castration Sensitive Prostate Cancer Clinical Trials Localized Prostate Cancer Biomarkers Androgen Ablation Therapy Stereotactic Body Radiation Therapy MRI Utilization Diagnosis Methods Research Studies Psychological Impact Detection Methods Risk Factors Symptoms Research CDK12/13 Inactivation Surgical Treatment Enzalutamide FDA Approved Drugs Metastatic Hormone-Sensitive Prostate Cancer Survival Rates Patient Care Technological Advances Salvage Radiotherapy Screening Methods Hormonal Therapy BRCA Mutations PTEN-deficient Tumors Metastatic Disease VIR-5500 Hormone-Sensitive Prostate Cancer Treatment Options Advanced Prostate Cancer Metastatic Castration-Resistant Prostate Cancer Treatment Side Effects Diagnosis and Treatment HRR Mutations

Phase 3 Trials at ASTRO Strengthen Case for Focused, Short‑Course Radiation

The data show five‑session SBRT and multi‑session postoperative radiosurgery preserve function or cut local recurrence, signaling potential changes to treatment discussions and guideline reviews.

Erleada Plus Hormone Therapy Cuts Recurrence and Death in High‑Risk Localized Prostate Cancer

FDA Panel Rejects AstraZeneca Breast Cancer Drug, Backs Prostate Therapy

Pfizer’s Talzenna Plus Xtandi Delivers Phase 3 Win in Hormone-Sensitive Prostate Cancer

Astellas–Vir Prostate Cancer Alliance Launches With New Data as VIR Stock Surges

Study Links PSMA PET/CT to 5-Year Outcomes, Informing Salvage Treatment After Prostatectomy

Final EMBARK Results Show 40% Lower Mortality With Enzalutamide Plus Leuprolide in High-Risk Recurrent Prostate Cancer

CDK12/13 Degraders Activate STING-Mediated Immunity and Enhance Checkpoint Therapy